Intermission 1: Effrossyni Gkrania-Klotsas

•Download as PPT, PDF•

0 likes•347 views

Effrossyni Gkrania-Klotsas: “Is it really helpful to talk about infectious diseases and Noncommunicable diseases separately?”

Health & Medicine Technology

Is it really helpful to talk about communicable and non-communicable diseases separately? Effrossyni Gkrania-Klotsas

UNAIDS/WHO Global HIV Case Response 2011

Morbidity Prevalence, 2004 ,[object Object],[object Object],WHO

Estimated annual childhood deaths from vaccine preventable diseases, 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

Zur Hausen, Virology, 392(1); 15 September 2009, 1-10

David M. Morens, Gregory K. Folkers & Anthony S. Fauci Nature 430, 242-249(8 July 2004)

Infectious Diseases are affected by climate change

CD and non-CD? ,[object Object],[object Object],[object Object]

What's hot

Emerging and Re-emerging Infectious Diseases

Farooq Khan

Virology- Emerging & Reemerging Viral Diseases

Maham Adnan

Emerging and re-emerging diseases

Atik shuvo

Emerging and Re-emerging Infectious Diseases

Shaharul Sohan

Emerging and re emerging diseases (part 1 of 2)

Dr. Mamta Gehlawat

Emerging and re-emerging infectious diseases: a key issue of governance for h...

WHO Regional Office for Europe

Emerging And Re Emerging Infectious Disease Vaccines 09 Dec08 Final

rwmalonemd

Dengue fever

Lin Smith

GDA - Superbugs and the role of diagnostics explained

Shweta Kulkarni Van Biesen

Viral emerging and re emerging diseases

GSL medical college

Realising the role of in vitro diagnostics in tackling antibiotic resistance, the European Diagnostic Manufacturers Association (EDMA) in conjunction with AdvamedDx and GMTA hosted a side-event at the WHO’s World Health Assembly “The Fight Against Antimicrobial Resistance: Are Diagnostics Winning?” The event identified existing gaps in tackling AMR while highlighting the role of diagnostics. So what is the role of diagnostics in antibiotic resistance? Are diagnostics winning?

Superbugs and the role of diagnostics explained

eucomed

Emerging infections dr rosni

mayazulkifli

Emerging viral dseaes

SURAMYA BABU

Presentation on Emerging and reEmerging infectious diseases

Basharat Rashid

emerging and re-emerging vector borne diseases

Anil kumar

Tb burden of disease

Pandurangi Raghavendra

Basic concepts of tuberculosis

Ashraf ElAdawy

Tuberculosis2015

tire321

Emerging infectious diseases paper 203

karishma purkayastha

Emerging and Re-emerging Diseases

Jasmine Nikki Versoza

What's hot (20)

Emerging and Re-emerging Infectious Diseases

Virology- Emerging & Reemerging Viral Diseases

Emerging and re-emerging diseases

Emerging and Re-emerging Infectious Diseases

Emerging and re emerging diseases (part 1 of 2)

Emerging and re-emerging infectious diseases: a key issue of governance for h...

Emerging And Re Emerging Infectious Disease Vaccines 09 Dec08 Final

Dengue fever

GDA - Superbugs and the role of diagnostics explained

Viral emerging and re emerging diseases

Superbugs and the role of diagnostics explained

Emerging infections dr rosni

Emerging viral dseaes

Presentation on Emerging and reEmerging infectious diseases

emerging and re-emerging vector borne diseases

Tb burden of disease

Basic concepts of tuberculosis

Tuberculosis2015

Emerging infectious diseases paper 203

Emerging and Re-emerging Diseases

Viewers also liked

The arguments for more funding towards tropical infectious

The Humanitarian Centre

Tolerfnt festival

lyceum179spb

Session 3: Nick Wareham

The Humanitarian Centre

Session 1: Nicola Watt

The Humanitarian Centre

Session 3: Felicity Jones

The Humanitarian Centre

Session 1: Modi Mwatsama

The Humanitarian Centre

Session 3: Amos Deogratius Mwaka

The Humanitarian Centre

Introduction: Richard Smith

The Humanitarian Centre

Viewers also liked (8)

The arguments for more funding towards tropical infectious

Tolerfnt festival

Session 3: Nick Wareham

Session 1: Nicola Watt

Session 3: Felicity Jones

Session 1: Modi Mwatsama

Session 3: Amos Deogratius Mwaka

Introduction: Richard Smith

Similar to Intermission 1: Effrossyni Gkrania-Klotsas

Communicabledisease

The NOPE International Institute

ABC Communicabledisease

Sumbit Chaliha

Global health

Matthew Rollosson

Tuberculosis Control in Cuba and Haiti

Kathryn Cicerchi

Non-Communicable Diseases: The Unheralded Global Epidemic_Meer_5.12.11

CORE Group

Communicable diseases

toshu97

Communicable diseasesohiri (1)

toshu97

Superbugs and the Role of Diagnostics Explained

Shweta Kulkarni Van Biesen

Neglected tropical diseases

Rajesh Karyakarte

uptodate HIV in pediatrics 2022 BY MWEBAZA VICTOR.pptx

Dr. MWEBAZA VICTOR

HIV in pediatrics 2022.pptx

Dr. MWEBAZA VICTOR

Imunizare in infectii

ClaudinaCobzariu

Public health disease pandemics

jharm35

EMERGING INFECTION DISEASE.ppt

DianpratiwiAkbar

DGH Lecture Series: Heidi Larsen

UWGlobalHealth

Understanding Biodiversity and Health. Presentation by Richard Kock.

pensoftservices

Dengue Seminar September 2011

javed.khalil

Superbugs and the role of diagnostics explained

MedTech Europe

Epidemic Diseases

Help Writing Papers For College Scottsdale

Neglected Tropical Diseases - Sustaining the Drive

Rajesh Karyakarte

Similar to Intermission 1: Effrossyni Gkrania-Klotsas (20)

Communicabledisease

ABC Communicabledisease

Global health

Tuberculosis Control in Cuba and Haiti

Non-Communicable Diseases: The Unheralded Global Epidemic_Meer_5.12.11

Communicable diseases

Communicable diseasesohiri (1)

Superbugs and the Role of Diagnostics Explained

Neglected tropical diseases

uptodate HIV in pediatrics 2022 BY MWEBAZA VICTOR.pptx

HIV in pediatrics 2022.pptx

Imunizare in infectii

Public health disease pandemics

EMERGING INFECTION DISEASE.ppt

DGH Lecture Series: Heidi Larsen

Understanding Biodiversity and Health. Presentation by Richard Kock.

Dengue Seminar September 2011

Superbugs and the role of diagnostics explained

Epidemic Diseases

Neglected Tropical Diseases - Sustaining the Drive

More from The Humanitarian Centre

Intermission 2: Paul Chinnock

The Humanitarian Centre

Session 2: Mike Davies

The Humanitarian Centre

Session 4: Maya Morris

The Humanitarian Centre

Session 3: Ahmed Aboulghate

The Humanitarian Centre

Session 2: Carol Brayne

The Humanitarian Centre

Session 1: David Stuckler

The Humanitarian Centre

Abstract Charities, governments and other funders of research must prioritise the areas in which they allocate research funding. An old but unresolved issue, is the weight that should be given to questions that the general public feel need urgent answers. Other groups remind us of the unsolved pressing issues of the developing world and the responsibility we have developing preventive measures and treatments for tropical and orphan diseases. This keynote lecture, delivered by Professor Martin Bobrow, will introduce us to some considerations relating to science funding in this. Should global disease priorities, achievability of research goals or research quality be guiding funding allocation? As a society, do we need ethical guidelines that would drive future research agendas? Are these guidelines more urgently needed in recession times?

Introduction to issues in research funding allocation

The Humanitarian Centre

"Issues in Research Funding Allocation". Abstract Charities, governments and other funders of research must prioritise the areas in which they allocate research funding. An old but unresolved issue, is the weight that should be given to questions that the general public feel need urgent answers. Other groups remind us of the unsolved pressing issues of the developing world and the responsibility we have developing preventive measures and treatments for tropical and orphan diseases. This keynote lecture, delivered by Professor Martin Bobrow, will introduce us to some considerations relating to science funding in this. Should global disease priorities, achievability of research goals or research quality be guiding funding allocation? As a society, do we need ethical guidelines that would drive future research agendas? Are these guidelines more urgently needed in recession times? Speaker Martin Bobrow studied medicine in South Africa. He worked in Edinburgh and Oxford, before becoming Professor of Medical Genetics in Amsterdam, London and then Cambridge in 1995. He retired from this post in 2005. He has been Deputy Chairman of the Wellcome Trust, Chairman of ULTRA (Unrelated Living Transplant Regulating Authority), Chairman of COMARE (Department of Health Advisory Committee on radiation in the Environment), Deputy Chairman of the Nuffield Council on Bioethics, Chairman of the Muscular Dystrophy Campaign and a member of the Medical Research Council and the Human Genetics Advisory Commission.

Keynote Address by Martin Bobrow

The Humanitarian Centre

4th Dec 2010 International Development Course Timetable

The Humanitarian Centre

Jim platts presentation

The Humanitarian Centre

Ken banks

The Humanitarian Centre

'Emerging donors' and the changing landscape of development, by Emma Mawdsley

The Humanitarian Centre

More from The Humanitarian Centre (12)

Intermission 2: Paul Chinnock

Session 2: Mike Davies

Session 4: Maya Morris

Session 3: Ahmed Aboulghate

Session 2: Carol Brayne

Session 1: David Stuckler

Introduction to issues in research funding allocation

Keynote Address by Martin Bobrow

4th Dec 2010 International Development Course Timetable

Jim platts presentation

Ken banks

'Emerging donors' and the changing landscape of development, by Emma Mawdsley

Recently uploaded

Aptopadesha Pramana / Pariksha: The Verbal Testimony

Dr KHALID B.M

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

Catherine Liao

Effects of vaping e-cigarettes on arterial health

Catherine Liao

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

AkashGanganePatil1

US E-cigarette Summit: Taming the nicotine industrial complex

Clive Bates

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

gauripg8

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

Catherine Liao

### Understanding Wealth: A Comprehensive Guide Wealth is a multifaceted concept that extends beyond mere financial assets. It encompasses a range of elements including money, investments, property, and other valuable resources. However, true wealth also includes non-material aspects such as health, relationships, and personal fulfillment. This guide delves into the various dimensions of wealth, exploring how it can be created, sustained, and enjoyed. #### Defining Wealth Traditionally, wealth is defined as the abundance of valuable resources or material possessions. It includes financial assets like cash, savings, stocks, bonds, and real estate. However, a broader understanding of wealth considers factors such as personal well-being, emotional health, social connections, and intellectual growth. This holistic view recognizes that true wealth is not solely about accumulating money but also about enhancing one's quality of life. #### The Importance of Financial Wealth Financial wealth remains a critical component of overall wealth. It provides security, freedom, and the ability to pursue opportunities. Key elements of financial wealth include: 1. **Savings**: Money set aside for future use. It is crucial for emergencies, large purchases, and financial goals. 2. **Investments**: Assets purchased with the expectation that they will generate income or appreciate over time. Common investments include stocks, bonds, mutual funds, real estate, and businesses. 3. **Income**: Regular earnings from work, investments, or other sources. Consistent income is essential for maintaining and growing wealth. 4. **Debt Management**: Effectively managing debt ensures that it does not erode financial wealth. This includes paying off high-interest debt and using credit wisely. #### Creating Wealth Creating wealth involves generating and accumulating financial and non-financial resources. The process can be broken down into several key strategies: 1. Education and Skill Development: Investing in education and skills enhances earning potential. Higher education, professional certifications, and continuous learning can lead to better job opportunities and higher salaries. 2. Entrepreneurship: Starting and running a successful business can be a significant source of wealth. Entrepreneurship requires innovation, risk-taking, and effective management. 3. Investing: Making smart investments is essential for wealth creation. This involves understanding different types of investments, assessing risks, and making informed decisions. Diversifying investments can reduce risk and increase potential returns. 4. Saving and Budgeting: Effective saving and budgeting help accumulate wealth over time. Setting financial goals, creating a budget, and sticking to it are foundational steps in wealth creation. 5. Real Estate: Investing in property can provide rental income and capital appreciation. Real estate is a tangible asset that can hedge against inflation

Mastering Wealth: A Path to Financial Freedom

FatimaMary4

Retinal consideration in cataract surgery

KafrELShiekh University

Ocular injury ppt Upendra pal optometrist upums saifai etawah

pal078100

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

Bright Chipili

Arterial health throughout cancer treatment and exercise rehabilitation in wo...

Catherine Liao

Contact us if you are interested: Email / Skype : kefaya1771@gmail.com Threema: PXHY5PDH New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH ! Contact me on Threema or skype to start big business!! Hot-sale products: NEW HOT EUTYLONE WHITE CRYSTAL!! 5cl-adba precursor (semi finished ) 5cl-adba raw materials ADBB precursor (semi finished ) ADBB raw materials APVP powder 5fadb/4f-adb Jwh018 / Jwh210 Eutylone crystal Protonitazene (hydrochloride) CAS: 119276-01-6 Flubrotizolam CAS: 57801-95-3 Metonitazene CAS: 14680-51-4 Payment terms: Western Union,MoneyGram,Bitcoin or USDT. Deliver Time: Usually 7-15days Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet. Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details. We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

GL Anaacs

Anuman- An inference for helpful in diagnosis and treatment

abdeli bhadarva

Fundamental of Radiobiology -SABBU.pptx

Sabbu Khatoon

TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...

kevinkariuki227

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

Catherine Liao

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

Recently uploaded (20)

Aptopadesha Pramana / Pariksha: The Verbal Testimony

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

Effects of vaping e-cigarettes on arterial health

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

US E-cigarette Summit: Taming the nicotine industrial complex

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

Mastering Wealth: A Path to Financial Freedom

Retinal consideration in cataract surgery

Ocular injury ppt Upendra pal optometrist upums saifai etawah

ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx

Arterial health throughout cancer treatment and exercise rehabilitation in wo...

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

Anuman- An inference for helpful in diagnosis and treatment

Fundamental of Radiobiology -SABBU.pptx

TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

Evaluation of antidepressant activity of clitoris ternatea in animals